Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iTIPS: Isoniazid for TB prevention in HIV-exposed infants
NCT02613169Phase 2Completed
- Sponsor
- University of Washington
- Start
- Aug 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isoniazid in Tuberculosis (TB), sponsored by University of Washington. Started Aug 2016; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02613169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613169.